Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients?

Grégory Dubourg (1) , Jean-Christophe Lagier (1) , Philippe Brouqui (1) , Jean-Paul Casalta (2) , Véronique Jacomo (3) , Bernard La Scola (1) , Jean-Marc Rolain (1) , Didier Raoult (1, 2)

1 MEPHI - Microbes évolution phylogénie et infections
2 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection
3 Eurofins Biomnis

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Life Sciences [q-bio]; Microbiology and Parasitology; Virology; Life Sciences [q-bio]; Microbiology and Parasitology; Parasitology; Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Emerging diseases; Life Sciences [q-bio]; Human health and pathology; Infectious diseases

Grégory Dubourg, Jean-Christophe Lagier, Philippe Brouqui, Jean-Paul Casalta, Véronique Jacomo, et al.. Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients?. Journal of Microbiology, Immunology and Infection, 2021, 54 (5), pp.997-1000. ⟨10.1016/j.jmii.2021.01.012⟩. ⟨hal-03437044⟩